Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

A new study has found that taking a small daily dose of aspirin could help stop colon cancer from returning in some patients.

Daily low-dose aspirin reduced the risk for colorectal cancer recurrence by roughly half in patients with mutations in the ...

In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on colorectal cancer (CRC) ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...

Aspirin has been shown to effectively reduce recurrence rates and improve disease-free survival,” said Anna Martling, MD, PhD.

A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

Safety: Aspirin was well-tolerated, with no major safety concerns reported. The ASCOLT trial showed that aspirin did not ...

Recent research published in JAMA Oncology has unveiled compelling evidence that regular aspirin consumption may significantly reduce the risk of developing colorectal cancer, particularly among ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.